Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton C Mason

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Blood Cancer Discovery|May 24, 2021
Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood CancersJulie E Feusier, Sasi Arunachalam, Tsewang Tashi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention programAllan F Moore, Kathleen A Jablonski, Clinton C Mason, et al.
Plos One|September 18, 2012
Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention ProgramJose C Florez, Kathleen A Jablonski, Jarred B McAteer, et al.
The Journal of Clinical Investigation|June 22, 2021
The clear cell sarcoma functional genomic landscapeEmanuele Panza, Benjamin B Ozenberger, Krystal M Straessler, et al.
Pediatric Blood & Cancer|December 14, 2016
Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissuesJulia A Meyer, Delu Zhou, Clinton C Mason, et al.
Cancers|October 13, 2021
Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in MyelofibrosisSimone Claudiani, Clinton C Mason, Dragana Milojkovic, et al.
Leukemia Research|February 15, 2017
Genomic analysis of adult B-ALL identifies potential markers of shorter survivalShiven Patel, Clinton C Mason, Martha J Glenn, et al.
Blood|January 10, 2015
shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistanceJamshid S Khorashad, Anna M Eiring, Clinton C Mason, et al.
Blood|December 11, 2012
BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationshipsJamshid S Khorashad, Todd W Kelley, Philippe Szankasi, et al.
British Journal of Haematology|December 1, 2022
Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborativeZeinab Afify, Manuela Orjuela-Grimm, Christine Moore Smith, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Blood Cancer Discovery|May 24, 2021
Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood CancersJulie E Feusier, Sasi Arunachalam, Tsewang Tashi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention programAllan F Moore, Kathleen A Jablonski, Clinton C Mason, et al.
Plos One|September 18, 2012
Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention ProgramJose C Florez, Kathleen A Jablonski, Jarred B McAteer, et al.
The Journal of Clinical Investigation|June 22, 2021
The clear cell sarcoma functional genomic landscapeEmanuele Panza, Benjamin B Ozenberger, Krystal M Straessler, et al.
Pediatric Blood & Cancer|December 14, 2016
Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissuesJulia A Meyer, Delu Zhou, Clinton C Mason, et al.
Cancers|October 13, 2021
Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in MyelofibrosisSimone Claudiani, Clinton C Mason, Dragana Milojkovic, et al.
Leukemia Research|February 15, 2017
Genomic analysis of adult B-ALL identifies potential markers of shorter survivalShiven Patel, Clinton C Mason, Martha J Glenn, et al.
Blood|January 10, 2015
shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistanceJamshid S Khorashad, Anna M Eiring, Clinton C Mason, et al.
Blood|December 11, 2012
BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationshipsJamshid S Khorashad, Todd W Kelley, Philippe Szankasi, et al.
British Journal of Haematology|December 1, 2022
Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborativeZeinab Afify, Manuela Orjuela-Grimm, Christine Moore Smith, et al.
Pageof 4